Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
13F holders, Q4 2025
Institutional positions in Cero Therapeutics Holdings, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- −21 vs. Q3 2025
- Shares held
- 2.50K
- −2.84M (−99.9%) vs. Q3 2025
- Total value
- $22
- −$38.1K (−99.9%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 21
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CEROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $22 |
| Q3 2025 | 22 | $38.1K |
| Q2 2025 | 23 | $74.5K |
| Q1 2025 | 26 | $45.7K |
| Q4 2024 | 27 | $28.6K |
| Q3 2024 | 31 | $28.0K |
| Q2 2024 | 35 | $110.3K |
| Q1 2024 | 38 | $425.3K |
| Q4 2023 | 41 | $135.1K |
| Q3 2023 | 44 | $423.7K |
| Q2 2023 | 44 | $351.0K |
| Q1 2023 | 47 | $234.9K |
| Q4 2022 | 50 | $264.8K |
| Q3 2022 | 44 | $503.0K |
| Q2 2022 | 42 | $550.0K |
| Q1 2022 | 36 | $1.02M |
| Q4 2021 | 31 | $1.35M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 2,500 | $22 | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 0 | $0 | 0.00% | −461,653−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −381,018−100.0% | Sold out |
| MMCAP International Inc. SPC | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Saba Capital Management, L.P. | 0 | $0 | 0.00% | −295,913−100.0% | Sold out |
| Linden Advisors LP | 0 | $0 | 0.00% | −249,999−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −224,930−100.0% | Sold out |
| Q Global Advisors, LLC | 0 | $0 | 0.00% | −170,785−100.0% | Sold out |
| Context Capital Management, LLC | 0 | $0 | 0.00% | −122,013−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −108,741−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −98,468−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −74,998−100.0% | Sold out |
| Tenor Capital Management Co., L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −33,796−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −23,250−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Silver Rock Financial LP | 0 | $0 | 0.00% | −12,224−100.0% | Sold out |
| Fortress Financial Solutions, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,104−100.0% | Sold out |